The Sharp Mesa Vista is a psychiatric hospital run by Sharp HealthCare. It opened in 1998. The facility has 149 licensed beds.

There are 149 beds in Sharp Mesa Vista Hospital.

During the past decade, Sharp Mesa Vista Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 18 clinical trials were completed, i.e. on average, 138.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sharp Mesa Vista Hospital" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Sunovion" with 4 trials sponsored and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 4 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sharp Mesa Vista Hospital" #1 collaborator was "Otsuka America Pharmaceutical" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Sharp Mesa Vista Hospital" are "Alzheimer's Disease" (8 trials), "Schizophrenia" (7 trials), "Alzheimer Disease" (5 trials), "Major Depressive Disorder" (4 trials) and "Bipolar Depression" (2 trials). Many other conditions were trialed in "Sharp Mesa Vista Hospital" in a lesser frequency.

Most popular intervention types in "Sharp Mesa Vista Hospital" are "Drug" (35 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "placebo" (4 trials), "Aripiprazole" (2 trials), "BMS-820836" (2 trials) and "Bapineuzumab 0.5 mg/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sharp Mesa Vista Hospital" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Sharp Mesa Vista Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Sharp Mesa Vista Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Sharp Mesa Vista Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".